Nykode Therapeutics (Formerly Vaccibody*)) Enters Into Multi-target License and Collaboration Agreem…

OSLO, Norway–(BUSINESS WIRE)–Nykode Therapeutics (formerly Vaccibody^*)) (Euronext Growth (Oslo): VACC), a clinical-stage biopharmaceutical company dedicated to the discovery and development of vaccines and novel immunotherapies, announced today that it has entered into a license and…